CELTYMAX, created in 2013 (Switzerland), from 2951 sister brands and 17477 competing brands. The CELTYMAX brand is owned by NOVARTIS N, a company listed in Zurich. The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. CELTYMAX belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(CELTYMAX)
over 5 years*
CHF 103.21